Company intelligence
Cerevance
Biotechnology Research
Boston, US
31 employees
Founded 2016
3 public signals
About Cerevance
Cerevance
Verified activity
Signals from Cerevance
3 published signals
Research & Knowledge
Cerevance conducted a Phase 3 ARISE study targeting a pathway outside of dopamine for people living with Parkinson’s disease experiencing OFF time.
Reported by Cerevance
Presence & Recognition
Cerevance is hosting the IlluminATion Biopharma Leadership Ball at the Museum of Fine Arts in Boston on September 26th.
Reported by Brad Margus
Research & Knowledge
Cerevance is conducting an ongoing study evaluating motor and non-motor measures of an investigational therapy for Parkinson's disease.
Reported by Cerevance